Skip to main content
. 2015 Jul 11;51:241–251. doi: 10.1007/s00535-015-1102-z

Fig. 1.

Fig. 1

Study schema (a), patient disposition (b). IFX infliximab; UC ulcerative colitis; IC informed consent